Rob Kim has extensive experience in the pharmaceutical sales industry, having held various roles at prestigious companies. At GlaxoSmithKline, Rob served as a Pharmaceutical Sales Representative, Senior Respiratory Therapeutic Specialist, Medical Center Sales Representative, Oncology Account Manager, and District Sales Manager for the Respiratory division between April 2006 and March 2008. Following this, Rob worked at Genentech as a Clinical Specialist for Esbriet (pirfenidone) targeting Idiopathic Pulmonary Fibrosis and later as Division Manager for the same product until December 2015. From January 2019 to October 2020, Rob was an Oncology Account Manager for Trodelvy (sacituzumab govitecan) at Immunomedics, focusing on Triple-Negative Breast Cancer and Urothelial Cancer. Currently, Rob is an Oncology Executive Therapeutic Specialist for Trodelvy at Gilead Sciences since October 2020. Rob holds a Bachelor of Business Administration in Marketing from the University of Cincinnati College of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices